Design of a Novel Genetically Engineered Vaccine Against Mycobacterium leprae
Leprosy, caused by Mycobacterium leprae is a granulomatous disease of the peripheral nervous system, causing permanent damage to the nerves, skin and limbs. It mainly affects the people living below the poverty. The current immunization strategies against leprosy like the BCG vaccine face several limitations and thus there is a need for an effective counter measure. The main aim was to design a vaccine with a genetically modified strain of the non-pathogenic Mycobacterium smegmatis which over-expressed the immunedominant protein that would induce a strong, non-toxic cell-mediated immune response, and the production of memory cells would lead to successful immunization against leprosy..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2014 |
|---|---|
| Erschienen: |
2014 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
Immunology, endocrine & metabolic agents in medicinal chemistry - 14(2014), 2, Seite 67-74 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
S. Devi, Chandiaserasekeran [VerfasserIn] |
|---|
| Links: |
|---|
| BKL: |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1986720772 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC1986720772 | ||
| 003 | DE-627 | ||
| 005 | 20230518124702.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 170131s2014 xx |||||o 00| ||eng c | ||
| 028 | 5 | 2 | |a fidpha_zeitschriften_20170130.pp |
| 035 | |a (DE-627)OLC1986720772 | ||
| 035 | |a (DE-599)GBVOLC1986720772 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |
| 084 | |a PHARM |2 fid | ||
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a S. Devi, Chandiaserasekeran |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Design of a Novel Genetically Engineered Vaccine Against Mycobacterium leprae |
| 264 | 1 | |c 2014 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Leprosy, caused by Mycobacterium leprae is a granulomatous disease of the peripheral nervous system, causing permanent damage to the nerves, skin and limbs. It mainly affects the people living below the poverty. The current immunization strategies against leprosy like the BCG vaccine face several limitations and thus there is a need for an effective counter measure. The main aim was to design a vaccine with a genetically modified strain of the non-pathogenic Mycobacterium smegmatis which over-expressed the immunedominant protein that would induce a strong, non-toxic cell-mediated immune response, and the production of memory cells would lead to successful immunization against leprosy. | ||
| 700 | 1 | |a Sarkar, Prithwijit |e verfasserin |4 aut | |
| 700 | 1 | |a Bhagavatula, Shreya |e verfasserin |4 aut | |
| 700 | 1 | |a Chatterjee, Shruti |e verfasserin |4 aut | |
| 700 | 1 | |a D. Sisoudiya, Saumya |e verfasserin |4 aut | |
| 700 | 1 | |a John, Carolyn |e verfasserin |4 aut | |
| 700 | 1 | |a Mohanasrinivasan, Vaithilingam |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Immunology, endocrine & metabolic agents in medicinal chemistry |d San Francisco, Calif. : Bentham Science Publ., 2006 |g 14(2014), 2, Seite 67-74 |w (DE-627)507526643 |w (DE-600)2221719-8 |w (DE-576)435514261 |x 1871-5222 |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2014 |g number:2 |g pages:67-74 |
| 856 | 4 | 0 | |u http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1871-5222&volume=14&issue=2&spage=67 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 936 | b | k | |a 44.40 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 14 |j 2014 |e 2 |h 67-74 | ||